Intestinal dysbiosis, obesity and metabolic syndrome: how to quit this tricky triangle?
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 4
Abstract
The paper presents analysis of the data of worldwide literature, results of evidence-based experimental and clinical trials on the relationship between dietary habits and intestinal microbiota. The particular attention is paid to the involvement of intestinal dysbiosis and small intestinal bacterial overgrowth syndrome in the pathogenesis of obesity and metabolic syndrome. The arguments in favour of two leading hypotheses have been outlined: hypothesis of metabolic endotoxemia and «storage» hypothesis. The first one considers mechanisms of the effects of lipopolysaccharide Gram-negative intestinal flora, increased permeability of intestinal wall, endocannabinoid system, and intestinal alkaline phosphatase. The «storage» hypothesis takes into account the peculiarities of food polysaccharides’ fermentation, monosaccharides’ absorption, and the role of intestinal microbiota and metabolites of its vital activity (in particular, short-chain fatty acids) in the regulation of lipid metabolism. Particular attention is paid to the treatment: dietary changes, the use of pro- and prebiotics, fecal transplantation. The effects of food components on the intestinal microbiota have been analysed, including the dietary fiber, such as resistant starch and inulin, and fats and proteins. It has been shown that the composition of the intestinal microbiota reflects the dietary habits and composition of the diet. A high-fat diet dramatically increases the intestinal permeability due to a mechanism associated with reduced expression of proteins of epithelial tight junction, including zonulin and occludin. The substantiation has been given to the hypothesis that the intestinal microbiome associated with obesity has an increased ability to receive energy from food («accumulation effect»). Benefits of an antibiotic with a low intestinal absorption (rifaximin) have been analysed. The results of studies supporting the eubiotic properties of rifaximin and its effectiveness at intestinal dysbiosis have been presented.
Authors and Affiliations
N. B. Gubergrits, N. V. Byelyayeva, O. V. Tsys, V. S. Rachmetova
Keywords
Related Articles
- EP ID EP670137
- DOI 10.30978/MG-2019-4-45
- Views 145
- Downloads 0
Predictors of irritable bowel syndrome formation among students
Objective — to establish the role of the nervous system disorders in the formation of irritable bowel syndrome (IBS) among students. Materials and methods. Examination involved 32 students with IBS, aged 19 to 26 years....
Chronic constipation: mechanisms of development and treatment tactics
The article presents recent concepts on the mechanisms of development and treatment of constipation. Classification of laxatives drugs is given. The medicinal plants, included in the composition of Izidu preparation, giv...
Non-cirrhotic portal hypertension: clinical case and literature review
Non-cirrhotic portal hypertension can be caused by many factors. The authors presented a clinical case of portal hypertension that was eventually determined to be caused by repeated microthrombotic events on the basis of...
The peculiarities of some gastroenterological diseases in elderly patients
The data presented in the paper were based on the recent investigations and currentrecommendations. The pathological changes in the gastroenterological profile are proved to be most prevalent in subjects aged 65 years an...
Clinical Practice Guidelines of European Association for the Study of the Liver (EASL) on nutrition in chronic liver disease. Part 3
_